Johnson & Johnson’s one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration staff said in documents published on Wednesday, paving the way for its approval for emergency use.
Single dose of Johnson & Johnson vaccine is 66% effective, say U.S. regulators
